Initial Statement of Beneficial Ownership (3)
July 02 2018 - 5:36PM
Edgar (US Regulatory)
FORM 3
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES
|
OMB APPROVAL
OMB Number:
3235-0104
Estimated average burden
hours per response...
0.5
|
|
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
|
|
1. Name and Address of Reporting Person
*
White Winston Select Asset Fund Series Fund MP-18, LLC
|
2. Date of Event Requiring Statement (MM/DD/YYYY)
6/22/2018
|
3. Issuer Name
and
Ticker or Trading Symbol
MusclePharm Corp [MSLP]
|
(Last)
(First)
(Middle)
265 FRANKLIN ST., SUITE 1702,
|
4. Relationship of Reporting Person(s) to Issuer (Check all applicable)
_____ Director
___
X
___ 10% Owner
_____ Officer (give title below)
_____ Other (specify below)
|
(Street)
BOSTON, MA 02110
(City)
(State)
(Zip)
|
5. If Amendment, Date Original Filed
(MM/DD/YYYY)
|
6. Individual or Joint/Group Filing
(Check Applicable Line)
___ Form filed by One Reporting Person
_
X
_ Form filed by More than One Reporting Person
|
Table I - Non-Derivative Securities Beneficially Owned
|
1.Title of Security
(Instr. 4)
|
2. Amount of Securities Beneficially Owned
(Instr. 4)
|
3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)
|
4. Nature of Indirect Beneficial Ownership
(Instr. 5)
|
Common Stock, par value $0.001 per share
|
2927677
|
D
|
|
Table II - Derivative Securities Beneficially Owned (
e.g.
, puts, calls, warrants, options, convertible securities)
|
1. Title of Derivate Security
(Instr. 4)
|
2. Date Exercisable and Expiration Date
(MM/DD/YYYY)
|
3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)
|
4. Conversion or Exercise Price of Derivative Security
|
5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)
|
6. Nature of Indirect Beneficial Ownership
(Instr. 5)
|
Date Exercisable
|
Expiration Date
|
Title
|
Amount or Number of Shares
|
Explanation of Responses:
|
Remarks:
White Winston Select Asset Funds, LLC is an indirect beneficial owner of 2,927,677 shares of Issuer's Common Stock, par value $0.001 per share, by virtue of being a member and the sole manager of White Winston Select Asset Fund Series Fund MP-18, LLC.
Messrs. Feagan, Blundell, Mahoney and Enright are indirect beneficial owners of 2,927,677 shares of Issuer's Common Stock, par value $0.001 per share, by virtue of being members and managers of White Winston Select Asset Funds, LLC, which is a member and the sole manager of White Winston Select Asset Fund Series Fund MP-18, LLC.
|
Reporting Owners
|
Reporting Owner Name / Address
|
Relationships
|
Director
|
10% Owner
|
Officer
|
Other
|
White Winston Select Asset Fund Series Fund MP-18, LLC
265 FRANKLIN ST., SUITE 1702
BOSTON, MA 02110
|
|
X
|
|
|
White Winston Select Asset Funds, LLC
265 FRANKLIN ST., SUITE 1702
BOSTON, MA 02110
|
|
X
|
|
|
Feagan Donald
C/O WHITE WINSTON SELECT ASSET FUNDS LLC
265 FRANKLIN ST., SUITE 1702
BOSTON, MA 02110
|
|
X
|
|
|
BLUNDELL MARK
C/O WHITE WINSTON SELECT ASSET FUNDS LLC
265 FRANKLIN ST., SUITE 1702
BOSTON, MA 02110
|
|
X
|
|
|
Mahoney Robert P
C/O WHITE WINSTON SELECT ASSET FUNDS LLC
265 FRANKLIN ST., SUITE 1702
BOSTON, MA 02110
|
|
X
|
|
|
Enright Todd M.
C/O WHITE WINSTON SELECT ASSET FUNDS LLC
265 FRANKLIN ST., SUITE 1702
BOSTON, MA 02110
|
|
X
|
|
|
Signatures
|
White Winston Select Asset Fund Series Fund MP-18, LLC, By: White Winston Select Asset Funds, LLC, its Manager, By: /s/ Todd M. Enright, Manager
|
|
7/2/2018
|
**
Signature of Reporting Person
|
Date
|
White Winston Select Asset Funds, LLC, By: /s/ Todd M. Enright, Manager
|
|
7/2/2018
|
**
Signature of Reporting Person
|
Date
|
/s/ Todd M. Enright
|
|
7/2/2018
|
**
Signature of Reporting Person
|
Date
|
/s/ Mark Blundell
|
|
7/2/2018
|
**
Signature of Reporting Person
|
Date
|
/s/ Donald Feagan
|
|
7/2/2018
|
**
Signature of Reporting Person
|
Date
|
/s/ Robert Mahoney
|
|
7/2/2018
|
**
Signature of Reporting Person
|
Date
|
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
|
*
|
If the form is filed by more than one reporting person,
see
Instruction 5(b)(v).
|
**
|
Intentional misstatements or omissions of facts constitute Federal Criminal Violations.
See
18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
|
Note:
|
File three copies of this Form, one of which must be manually signed. If space is insufficient,
see
Instruction 6 for procedure.
|
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
|
Muscle Pharm (CE) (USOTC:MSLP)
Historical Stock Chart
From Apr 2024 to May 2024
Muscle Pharm (CE) (USOTC:MSLP)
Historical Stock Chart
From May 2023 to May 2024
Real-Time news about Muscle Pharm Corporation (CE) (OTCMarkets): 0 recent articles
More Musclepharm Corp News Articles